Qianjin Pharmaceutical

What Qianjin Pharmaceutical does

Qianjin Pharmaceutical (株洲千金药业股份有限公司) is a Zhuzhou-based, state-controlled pharmaceutical group listed on the Shanghai Stock Exchange (stock code: 600479) and majority-owned by Zhuzhou State-owned Assets Investment Holding Group. Founded in 1966 as a traditional Chinese medicine processing factory and incorporated as a joint-stock company in 1993, the company operates 11 subsidiaries with approximately 5,400 employees, organized around three product pillars: Chinese patent medicines, chemical drugs, and derivative personal care products, with a vertically integrated retail pharmacy chain of nearly 2,000 stores in Hunan province.

The company's core franchise is women's health, anchored by the flagship Fuke Qianjin Tablets/Capsules (妇科千金片/胶囊), a gynecological anti-inflammatory TCM classified as National Secret-level technology that has held the #1 position in oral gynecological TCM market share for over a decade and contributed to 14 consecutive years of Health China Brand List Gynecology Gold Awards. The product portfolio also includes Buxue Yimu Pills/Granules (a National Essential Drug for postpartum recovery with sales exceeding 100 million yuan), Bazhen Yimu Tablets, Jiawei Xiaoyao Wan, plus chemical drugs (Montmorillonite Powder, Domperidone, Dydrogesterone), and derivative feminine hygiene/personal care brands (Qianjin Jingya sanitary products, Qianjin Run wash products). The group holds 403 patents as of 2024 and has secured 151 drug approvals and 23 API approvals as of May 2025.

The business operates a dual-channel distribution model: a hospital/medical institution channel targeting clinical adoption of NEDL products through academic promotion, and a retail pharmacy channel leveraging both a self-operated chain (Qianjin Pharmacy) and partnerships with national chains including Yifeng, Laobaixing, and Yixintang. Online sales are driven via Tmall, JD.com, Pinduoduo, Douyin, and Xiaohongshu, while feminine hygiene products reach mass-market consumers through Walmart, RT-Mart, and other supermarkets. Revenue is generated through one-time sales of pharmaceutical manufacturing and transaction-based wholesale/retail distribution, with pricing subject to China's National Reimbursement Drug List (NRDL) negotiations and national volume-based procurement (集采) policies. FY2021 revenue was 3.66 billion yuan, with the Qianjin Xiangjiang chemical drug subsidiary achieving 11% YoY growth and 4.28 billion yuan in 2025 collective procurement shipment value.

Name

Qianjin Pharmaceutical

Legal name

株洲千金药业股份有限公司 (Zhuzhou Qianjin Pharmaceutical Co., Ltd.)

Website

https://qjyy.com

Company type

Public

Founded year

1966

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Qianjin Pharmaceutical is a state-controlled Chinese pharmaceutical group focused on women's health, manufacturing TCM and chemical drugs (led by Fuke Qianjin Tablets), feminine hygiene products, and operating ~2,000 retail pharmacies in Hunan province.

Ownership category

akta.pro rank

Product category

Women's Health Pharmaceuticals (TCM and chemical drugs)

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmacies and Drug Retailers (456110), Health and Personal Care Retailers (456)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Specialty Care Pharmaceuticals (HLAIAAAB), Hand Sanitizers & Antibacterial Personal Care (CRADANAI)

Keywords

• Gynecological TCM
• Women's health pharmaceuticals
• Feminine hygiene products
• Chemical drug manufacturing
• Pharmacy chain retail

Headquarters

HQ city

Zhuzhou

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Manufacturing and Sales: Revenue from manufacturing and sales of TCM products (gynecological medicines, hematinics), chemical drugs (cardiovascular, antiviral, anti-hypertension), and health products including feminine hygiene items and derivative personal care products.
2. Pharmaceutical Wholesale and Retail: Revenue from pharmaceutical distribution through 株洲千金大药房连锁 (Qianjin Pharmacy Chain) with nearly 2000 stores in Hunan province, and wholesale distribution through 湖南千金医药股份有限公司 covering medical institutions and pharmacy terminals across Hunan.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

Zhuzhou Qianjin Pharmaceutical develops, manufactures, and sells Traditional Chinese Medicine and chemical drug products primarily focused on women's health, with flagship products including Fuke Qianjin Tablets/Capsules, Buxue Yimu Pills/Granules, and Bazhen Yimu Tablets for gynecological inflammation, menstrual disorders, and postpartum recovery. The company also manufactures chemical drugs for cardiovascular, antiviral, gastrointestinal, and hypertension indications, alongside feminine hygiene (Qianjin Jingya), personal care (Qianjin Run), and health products, distributed through hospital terminals, nearly 2,000 self-operated retail pharmacies, chain pharmacies, wholesale networks, and online e-commerce channels.

Product overview

千金药业是一家以女性健康为核心的综合医药企业，产品涵盖中成药、化学药和卫生用品三大板块。中成药以妇科千金片/胶囊为旗舰产品，辅以补血益母丸/颗粒、八珍益母片、加味逍遥丸等独家品种；化学药包括蒙脱石散、多潘立酮片等常用药及心脑血管、肝病类处方药；衍生品包括千金净雅卫生棉品系列和千金润洗护系列。2026年正式进军妇科化药领域，推出地屈孕酮片。

Differentiator

Problem solved

Functional benefit

Brands

• 千金净雅 (Qianjin Jingya): Medical-grade sanitary product brand specializing in gynecological care products including sanitary pads, nursing pads, and maternity products for women
• 千金润 (Qianjin Run)
• 千金养生坊 (Qianjin Health Wellness)
• 千金大药房 (Qianjin Pharmacy)
• 千金饮 (Qianjin Yin)

Products and services

• Fuke Qianjin Tablets (妇科千金片) Traditional Chinese Medicine tablets that clear heat, eliminate dampness, and tonify qi; indicated for leukorrhea, abdominal pain, chronic pelvic inflammation, endometritis, and chronic cervicitis caused by damp-heat stasis. Classified as National Essential Drug List product, NRDL Class A, and National Secret-level technology project. For women with gynecological inflammatory conditions.
• Fuke Qianjin Capsules (妇科千金胶囊) Capsule formulation of Fuke Qianjin for the same gynecological indications (leukorrhea, abdominal pain, chronic pelvic inflammation, endometritis, cervicitis). Classified as National Essential Drug, NRDL Class A, and National High-tech Product. Approved as a nationally protected TCM variety.
• Buxue Yimu Pills/Granules (补血益母丸/颗粒) Postpartum recovery TCM that nourishes blood and replenishes qi; one of only three National Essential Drug varieties in the postpartum recovery category. Sales exceeded RMB 100 million in 2021, becoming the company's second RMB 1 billion product. For women recovering after childbirth.
• Bazhen Yimu Tablets (八珍益母片) TCM that tonifies qi and blood and regulates menstruation; indicated for dizziness, palpitations, fatigue, scanty/light menstruation, and delayed menstrual cycles. For women with menstrual disorders and qi-blood deficiency.
• Jiawei Xiaoyao Wan (加味逍遥丸)

Quantifiable outcome

• Fuke Qianjin Tablets/Capsules maintained TOP 1 position in oral gynecological TCM market for over 10 consecutive years
• +3 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Partnerships

Twelve partnerships are on record, tiered major and core.

• Zhuzhou People's Hospital (株洲市人民医院)majorStrategic or Co-development Partner · 1 January 2026'Silver Hair Health Guardian' program collaboration. Hospital sends expert teams to Qianjin Pharmacy stores for free consultations on chronic disease management including hypertension and diabetes.
• Alibaba Cloud (阿里云)coreTechnology or Integration · 22 August 2025Strategic cooperation agreement signed August 2025 for comprehensive digital transformation. Alibaba Cloud to provide AI and data intelligence solutions for R&D, production, supply chain and marketing.
• Ant Group (蚂蚁集团)coreTechnology or Integration · 22 August 2025Part of three-party strategic cooperation signed August 2025 with Zhuzhou municipal government. Ant Group to provide digital payment and fintech solutions for healthcare services.
• Da Canlin Medical Group (大参林医药集团)majorGTM or Marketing Partner · 1 January 2021Corporate partner in women's health public education program since 2021. Health experts lecture to female employees and customers. Reached 200+ companies covering 50+ million female employees.
• Yifeng Pharmacy Chain (益丰大药房连锁)majorGTM or Marketing Partner · 1 January 2021Long-term cooperation partner in health education for pharmacy staff and female customers through women's health lectures.
• Laobaixing Pharmacy Chain (老百姓大药房连锁)majorGTM or Marketing Partner · 1 January 2021Corporate partner in women's health education program. Provides platform for expert lectures to pharmacy female staff and customers.
• Yixintang Pharmaceutical Group (一心堂药业集团)majorGTM or Marketing Partner · 1 January 2021Corporate partner in women's health public welfare initiative since 2021, extending health education to pharmacy network.
• Haiwang Xingchen Health Pharmacy (海王星辰健康药房)majorGTM or Marketing Partner · 1 January 2021Partner enterprise in women's health education initiative, reaching female employees and customers through expert health lectures.
• Qianjin Academy (千金研究院)coreStrategic or Co-development Partner · 1 January 2018Founded 2018 as group R&D center, technology innovation center, talent training center, scientific information center and think tank. Collaborates with 50+ research institutes including Peking University, 302 Hospital, Hunan University of Chinese Medicine, Central South University.
• Peking University / Hunan University of Chinese Medicine / Central South University / China Pharmaceutical UniversitymajorStrategic or Co-development Partner · 1 January 2018External expert network of 200+ experts collaborating with Qianjin Academy on R&D projects in pharmacy, derivatives, policy and clinical research.
• China Women Magazine (中国妇女杂志社)coreStrategic or Co-development Partner · 1 January 2016Co-founded 'Hello Qianjin - Women's Health China' public welfare initiative in 2016. Magazine publishes health education column reaching millions of female readers. Project has reached nearly 60 million people over 10 years.
• Zhejiang University / Tongji University / Nanjing University / Central South UniversitymajorGTM or Marketing Partner · 1 January 2016Universities that hosted 'Hello Qianjin' health lectures as part of women's health public welfare program reaching university students.

Scale indicators13 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Jointown Pharmaceutical Group: Top-tier Chinese pharmaceutical distributor and pharmacy chain operator. Comparable to Qianjin's wholesale/retail distribution arm (Qianjin Medicine and Qianjin Pharmacy Chain) and a relevant benchmark for the company's retail pharmacy ambitions outside Hunan.
• Shanghai Pharmaceuticals Holding: Major state-owned pharmaceutical group combining drug manufacturing, distribution and retail pharmacy operations. Comparable to Qianjin in integrating manufacturing with distribution/wholesale and pharmacy retail, though at significantly larger scale.
• Guangzhou Baiyunshan Pharmaceutical Holdings: One of China's largest integrated pharmaceutical conglomerates spanning TCM, chemical drugs, and consumer health products under the state-owned Guangzhou Pharmaceutical umbrella. Comparable to Qianjin at a much larger scale, sharing the diversified pharma + consumer health model.

Direct peers

• Yunnan Baiyao Group: Leading Chinese TCM pharmaceutical group with a similar integrated model spanning branded TCM products, chemical drugs, and consumer health/personal care. Both companies combine proprietary TCM formulas with consumer-facing brand-building and have diversified into adjacent health products, making them direct comparables in the branded TCM-pharma space.
• Pien Tze Huang (Zhangzhou Pien Tze Huang Pharmaceutical): Specialty TCM pharma focused on a flagship national-protected formula with strong consumer brand equity and premium pricing. Comparable to Qianjin as a TCM company deriving most of its value from a single flagship national-secret-level product and brand.
• CR Sanjiu (China Resources Sanjiu Medical & Pharmaceutical): Major branded Chinese TCM manufacturer with a strong OTC portfolio including women's health and pediatric categories. CR Sanjiu competes with Qianjin in retail pharmacy channels and shares the playbook of building consumer-recognized TCM brands included in NRDL/NEDL.
• Dong-E E-Jiao: Specialty TCM company built around a traditional formula (ejiao) with strong brand recognition, consumer health extensions, and A-share listing. Comparable to Qianjin's model of leveraging national-secret-level TCM heritage into branded consumer products and women's health adjacencies.
• Zhongxin Pharmaceutical (Tianjin Zhongxin Pharmaceutical Group): Diversified Chinese TCM pharmaceutical group with a portfolio of branded TCM products sold through both hospital and retail pharmacy channels. Comparable to Qianjin in terms of multi-category TCM product mix and national distribution via pharmacy chains.

Others

• Laobaixing Pharmacy Chain: Large national pharmacy chain and listed partner of Qianjin for women's health public welfare programs. Comparable as a major retail pharmacy customer and indirect competitor through its OTC women's health offerings across Hunan and nationally.

Regional players

• Yifeng Pharmacy Chain (Yifeng Drugstore): Major listed Chinese pharmacy chain and a direct customer/partner of Qianjin in the women's health education program. Relevant as both a downstream channel partner and a competitor in pharmacy retail; comparable as a major regional pharmacy operator (HQ in Hunan) overlapping Qianjin's home geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zhuzhou-qianjin-pharmaceutical-co-ltd-

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qianjin Pharmaceutical